Annual Current Liabilities
$23.26 M
-$2.71 M-10.43%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual total current liabilities is currently $23.26 million, with the most recent change of -$2.71 million (-10.43%) on 31 December 2023. ZBIO annual current liabilities is now -10.43% below its all-time high of $25.97 million, reached on 31 December 2022.ZBIO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$44.00 M
+$4.89 M+12.50%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly total current liabilities is currently $44.00 million, with the most recent change of +$4.89 million (+12.50%) on 30 September 2024. Over the past year, it has increased by +$28.44 million (+182.81%). ZBIO quarterly current liabilities is now at all-time high.ZBIO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.4% | +182.8% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ZBIO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.4% | at low | at high | +182.8% |
| 5 y | 5 years | -10.4% | at low | at high | +182.8% |
| alltime | all time | -10.4% | at low | at high | +182.8% |
ProShares UltraPro Short Nasdaq Biotechnology Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $44.00 M(+12.5%) |
| June 2024 | - | $39.11 M(+28.9%) |
| Mar 2024 | - | $30.33 M(+30.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $23.26 M(-10.4%) | $23.26 M(+49.5%) |
| Sept 2023 | - | $15.56 M |
| Dec 2022 | $25.97 M | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual total current liabilities?
- What is the all time high annual current liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology annual current liabilities year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly current liabilities year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual total current liabilities?
The current annual current liabilities of ZBIO is $23.26 M
What is the all time high annual current liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual total current liabilities is $25.97 M
What is ProShares UltraPro Short Nasdaq Biotechnology annual current liabilities year-on-year change?
Over the past year, ZBIO annual total current liabilities has changed by -$2.71 M (-10.43%)
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total current liabilities?
The current quarterly current liabilities of ZBIO is $44.00 M
What is the all time high quarterly current liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly total current liabilities is $44.00 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly current liabilities year-on-year change?
Over the past year, ZBIO quarterly total current liabilities has changed by +$28.44 M (+182.81%)